CENTRAL MU-OPIOID RECEPTORS ARE DOWN-REGULATED IN A RAT MODEL OF CHOLESTASIS

被引:108
作者
BERGASA, NV
ROTHMAN, RB
VERGALLA, J
XU, H
SWAIN, MG
JONES, EA
机构
[1] NIADDKD, MED CHEM LAB, BETHESDA, MD 20892 USA
[2] NIDA, ADDICT RES CTR, CLIN PSYCHOPHARMACOL LAB, BALTIMORE, MD USA
关键词
D O I
10.1016/0168-8278(92)90040-V
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ameliorations of the pruritus of cholestasis by opioid antagonists are consistent with this form of pruritus being centrally mediated by the opioid system. To determine whether the central opioid system is altered in cholestasis, the specific binding of a selective mu-opioid receptor ligand, H-3-DAMGO, to mu-opioid receptors was studied in rats with acute cholestasis due to bile duct resection. Using whole brain membranes and subcellular mitochondrial-synaptosomal fractions the density of mu-receptor sites was 30% (p < 0.01) and 22% (p = 0.03) less in bile-duct-resected rats than in sham-resected rats. Using membranes from individual brain regions specific binding of H-3-DAMGO was reduced by 43-53% in the cerebral cortex, hippocampus and caudate nucleus of bile-duct-resected rats. Thus mu-opioid receptors in the brain are down-regulated in a classical model of cholestasis. This alteration of the central opioid system could be a consequence of increased exposure of opioid receptors to endogenous opioids in cholestasis and may reflect an important mechanism in the pathogenesis of the pruritus of cholestasis.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 10 条
  • [1] ARNOLD HL, 1990, ANDREWS DISEASES SKI, P51
  • [2] A CONTROLLED TRIAL OF NALOXONE INFUSIONS FOR THE PRURITUS OF CHRONIC CHOLESTASIS
    BERGASA, NV
    TALBOT, TL
    ALLING, DW
    SCHMITT, JM
    WALKER, EC
    BAKER, BL
    KORENMAN, JC
    PARK, Y
    HOOFNAGLE, JH
    JONES, EA
    [J]. GASTROENTEROLOGY, 1992, 102 (02) : 544 - 549
  • [3] BERGASA NV, 1991, HEPATOLOGY, V14, pA154
  • [4] BERGASA NV, 1990, HEPATOLOGY, V12, P887
  • [5] HYPOTHESIS - THE PRURITUS OF CHOLESTASIS - FROM BILE-ACIDS TO OPIATE AGONISTS
    JONES, EA
    BERGASA, NV
    [J]. HEPATOLOGY, 1990, 11 (05) : 884 - 887
  • [6] LAIDLAW J, 1961, GASTROENTEROLOGY, V40, P389
  • [7] MALOTEAUX JM, 1989, N-S ARCH PHARMACOL, V339, P192
  • [8] CHRONIC ADMINISTRATION OF MORPHINE AND NALTREXONE UP-REGULATE MU-OPIOID BINDING-SITES LABELED BY [H-3][D-ALA2,MEPHE4,GLY-OL5]ENKEPHALIN - FURTHER EVIDENCE FOR 2 MU-BINDING SITES
    ROTHMAN, RB
    BYKOV, V
    LONG, JB
    BRADY, LS
    JACOBSON, AE
    RICE, KC
    HOLADAY, JW
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 160 (01) : 71 - 82
  • [9] TAO PL, 1987, J PHARMACOL EXP THER, V240, P809
  • [10] OPIOID-PEPTIDES AND PRIMARY BILIARY-CIRRHOSIS
    THORNTON, JR
    LOSOWSKY, MS
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6662) : 1501 - 1504